|
US4215051A
(en)
|
1979-08-29 |
1980-07-29 |
Standard Oil Company (Indiana) |
Formation, purification and recovery of phthalic anhydride
|
|
US5168062A
(en)
|
1985-01-30 |
1992-12-01 |
University Of Iowa Research Foundation |
Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence
|
|
US4690915A
(en)
|
1985-08-08 |
1987-09-01 |
The United States Of America As Represented By The Department Of Health And Human Services |
Adoptive immunotherapy as a treatment modality in humans
|
|
US5217891A
(en)
|
1987-07-28 |
1993-06-08 |
Chiron Corporation |
DNA constructs containing a kluyveromyces α factor leader sequence for directing secretion of heterologous polypeptides
|
|
DE68924162T2
(de)
|
1988-06-15 |
1996-04-25 |
Medical Res Council |
Stressproteine und verwendungen dafür.
|
|
US5137819A
(en)
|
1988-07-08 |
1992-08-11 |
University Of British Columbia |
Cellulose binding fusion proteins for immobilization and purification of polypeptides
|
|
WO1990002564A1
(en)
|
1988-09-12 |
1990-03-22 |
Codon |
Vaccine diagnostic employing proteins homologous to heat shock proteins of trypanosoma cruzi
|
|
US5232833A
(en)
|
1988-09-14 |
1993-08-03 |
Stressgen Biotechnologies Corporation |
Accumulation of heat shock proteins for evaluating biological damage due to chronic exposure of an organism to sublethal levels of pollutants
|
|
US5703055A
(en)
|
1989-03-21 |
1997-12-30 |
Wisconsin Alumni Research Foundation |
Generation of antibodies through lipid mediated DNA delivery
|
|
US5108921A
(en)
|
1989-04-03 |
1992-04-28 |
Purdue Research Foundation |
Method for enhanced transmembrane transport of exogenous molecules
|
|
US5399346A
(en)
|
1989-06-14 |
1995-03-21 |
The United States Of America As Represented By The Department Of Health And Human Services |
Gene therapy
|
|
EP0773294A3
(en)
|
1989-07-28 |
1997-09-17 |
Us Health |
Powerful system for targeted genetic cloning
|
|
GB9007194D0
(en)
|
1990-03-30 |
1990-05-30 |
Wellcome Found |
Live vaccines
|
|
US5348945A
(en)
|
1990-04-06 |
1994-09-20 |
Wake Forest University |
Method of treatment with hsp70
|
|
US5188964A
(en)
|
1990-04-12 |
1993-02-23 |
Board Of Regents, The University Of Texas System |
Method and kit for the prognostication of breast cancer patient via heat shock/stress protein determination
|
|
GB9016315D0
(en)
|
1990-07-25 |
1990-09-12 |
Burnie James P |
Medicaments
|
|
DE69126668T2
(de)
|
1990-11-08 |
1997-10-23 |
University College London, London |
Mycobacterium als adjuvans für antigene
|
|
GB9024320D0
(en)
|
1990-11-08 |
1990-12-19 |
Univ London |
Treatment of uveitis
|
|
GB2251186A
(en)
|
1990-12-04 |
1992-07-01 |
Randall Neal Gatz |
Polypeptide for use in treatment of autoimmune disease
|
|
AU643141B2
(en)
|
1991-03-15 |
1993-11-04 |
Amgen, Inc. |
Pulmonary administration of granulocyte colony stimulating factor
|
|
GB9200949D0
(en)
|
1992-01-17 |
1992-03-11 |
Medical Res Council |
Diagnostic peptides
|
|
FR2688227A1
(fr)
|
1992-03-04 |
1993-09-10 |
Inst Nat Sante Rech Med |
Proteines formant des complexes avec des chaperones et leurs ligands, leurs fragments, leur obtention et leurs applications biologiques.
|
|
IT1262896B
(it)
|
1992-03-06 |
1996-07-22 |
|
Composti coniugati formati da proteine heat shock (hsp) e oligo-poli- saccaridi, loro uso per la produzione di vaccini.
|
|
EP0630404A1
(en)
|
1992-03-09 |
1994-12-28 |
Istituto Nazionale Per Lo Studio E La Cura Dei Tumori Fondazione Giovanni Pascale |
Protein compound capable of inhibiting tumoral growth
|
|
EP0636248A4
(en)
|
1992-04-14 |
1996-11-13 |
Univ Duke |
METHOD FOR DETECTING P53 AND HSP70 COMPLEX CONTAINING TUMORS.
|
|
IL102687A
(en)
|
1992-07-30 |
1997-06-10 |
Yeda Res & Dev |
Conjugates of poorly immunogenic antigens and synthetic pepide carriers and vaccines comprising them
|
|
WO1994003599A1
(fr)
|
1992-08-04 |
1994-02-17 |
Sagami Chemical Research Center |
ADNc HUMAIN ET PROTEINE POUR LAQUELLE CODE CET ADNc
|
|
GB2270076A
(en)
|
1992-08-18 |
1994-03-02 |
Univ Manchester |
Human HSP 90 Epitopes
|
|
GB9223816D0
(en)
|
1992-11-13 |
1993-01-06 |
Medical Res Council |
Heat shock proteins and the treatment of tumours
|
|
CA2158655A1
(en)
|
1993-03-19 |
1994-09-29 |
Max L. Birnstiel |
Process for preparing cancer vaccines
|
|
US5496934A
(en)
|
1993-04-14 |
1996-03-05 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Nucleic acids encoding a cellulose binding domain
|
|
US5645829A
(en)
|
1993-06-18 |
1997-07-08 |
Beth Israel Hospital Association |
Mesothelial cell gene therapy
|
|
WO1995004824A1
(en)
|
1993-08-05 |
1995-02-16 |
Medvet Science Pty. Ltd. |
Generation of dna libraries and retroviral vectors for same
|
|
US5705159A
(en)
|
1993-08-31 |
1998-01-06 |
John Wayne Cancer Institute |
Immunoreactive peptide sequence from a 43 KD human cancer antigen
|
|
US5444087A
(en)
|
1993-10-19 |
1995-08-22 |
Bristol-Myers Squibb Company |
Manumycin compounds
|
|
US5750119A
(en)
|
1994-01-13 |
1998-05-12 |
Mount Sinai School Of Medicine Of The City University Of New York |
Immunotherapeutic stress protein-peptide complexes against cancer
|
|
US5997873A
(en)
|
1994-01-13 |
1999-12-07 |
Mount Sinai School Of Medicine Of The City University Of New York |
Method of preparation of heat shock protein 70-peptide complexes
|
|
WO1995022618A1
(en)
|
1994-02-22 |
1995-08-24 |
Dana-Farber Cancer Institute |
Nucleic acid delivery system, method of synthesis and uses thereof
|
|
US5961979A
(en)
|
1994-03-16 |
1999-10-05 |
Mount Sinai School Of Medicine Of The City University Of New York |
Stress protein-peptide complexes as prophylactic and therapeutic vaccines against intracellular pathogens
|
|
US5451569A
(en)
|
1994-04-19 |
1995-09-19 |
Hong Kong University Of Science And Technology R & D Corporation Limited |
Pulmonary drug delivery system
|
|
ATE172099T1
(de)
|
1994-07-08 |
1998-10-15 |
Baxter Int |
Implantierte vorrichtung mit tumorzellen zur behandlung von krebs
|
|
US5772995A
(en)
|
1994-07-18 |
1998-06-30 |
Sidney Kimmel Cancer Center |
Compositions and methods for enhanced tumor cell immunity in vivo
|
|
DK0784483T3
(da)
|
1994-10-03 |
2001-03-26 |
Us Gov Health & Human Serv |
Præparat indeholdende et rekombinant virus, der udtrykker et antigen, og et rekombinant virus, der udtrykker et immunstimul
|
|
US5703057A
(en)
|
1995-04-07 |
1997-12-30 |
Board Of Regents The University Of Texas System |
Expression library immunization
|
|
US6331299B1
(en)
|
1995-08-18 |
2001-12-18 |
Sloan-Kettering Institute For Cancer Research |
Method for treatment of cancer and infectious disease and compositions useful in same
|
|
US6719974B1
(en)
|
1995-08-18 |
2004-04-13 |
Sloan-Kettering Institute For Cancer Research |
Heat shock protein-based vaccines and immunotherapies
|
|
US6761892B1
(en)
|
1995-08-18 |
2004-07-13 |
Sloan-Kettering Institute For Cancer Research |
Heat shock protein-based vaccines and immunotherapies
|
|
CA2229543A1
(en)
|
1995-08-18 |
1997-02-27 |
Sloan-Kettering Institute For Cancer Research |
Heat shock protein-based vaccines and immunotherapies
|
|
US5935576A
(en)
|
1995-09-13 |
1999-08-10 |
Fordham University |
Compositions and methods for the treatment and prevention of neoplastic diseases using heat shock proteins complexed with exogenous antigens
|
|
US5985270A
(en)
|
1995-09-13 |
1999-11-16 |
Fordham University |
Adoptive immunotherapy using macrophages sensitized with heat shock protein-epitope complexes
|
|
US5837251A
(en)
|
1995-09-13 |
1998-11-17 |
Fordham University |
Compositions and methods using complexes of heat shock proteins and antigenic molecules for the treatment and prevention of neoplastic diseases
|
|
JPH11513369A
(ja)
|
1995-09-13 |
1999-11-16 |
フォーダム ユニバーシティー |
熱ショックタンパク質を用いる治療及び予防方法
|
|
DE19602985A1
(de)
|
1996-01-27 |
1997-07-31 |
Max Delbrueck Centrum |
Tumorzellimpfstoff für die Immuntheraphie von malignen Tumoren
|
|
WO1997026910A2
(de)
|
1996-01-27 |
1997-07-31 |
Max-Delbrück-Centrum für Molekulare Medizin |
Tumorimpfstoff für die immuntherapie von malignen tumoren
|
|
BR9708387A
(pt)
|
1996-03-28 |
2000-01-04 |
Genitrix Llc |
Processo para vacinação de um mamìfero a um antìgeno selecionado, células patogênica e hospedeira, composição de vacina, ácido nucleico, e, opsonina engenheirada.
|
|
US5747332A
(en)
|
1996-09-20 |
1998-05-05 |
University Of New Mexico |
Methods for purifying and synthesizing heat shock protein complexes
|
|
US6130087A
(en)
|
1996-10-07 |
2000-10-10 |
Fordham University |
Methods for generating cytotoxic T cells in vitro
|
|
EP0941315B1
(en)
|
1996-11-26 |
2006-03-01 |
Stressgen Biotechnologies Corporation |
Fusion proteins containing stress proteins for inducing immune responses
|
|
EP1012274B2
(en)
|
1997-01-28 |
2011-06-15 |
Human Genome Sciences, Inc. |
Death domain containing receptor 4 (dr4: death receptor 4), member of the tnf-receptor superfamily and binding to trail (ap0-2l)
|
|
US8329179B2
(en)
|
1997-01-28 |
2012-12-11 |
Human Genome Sciences, Inc. |
Death domain containing receptor 4 antibodies and methods
|
|
US7452538B2
(en)
|
1997-01-28 |
2008-11-18 |
Human Genome Sciences, Inc. |
Death domain containing receptor 4 antibodies and methods
|
|
US5830464A
(en)
|
1997-02-07 |
1998-11-03 |
Fordham University |
Compositions and methods for the treatment and growth inhibition of cancer using heat shock/stress protein-peptide complexes in combination with adoptive immunotherapy
|
|
US6017540A
(en)
|
1997-02-07 |
2000-01-25 |
Fordham University |
Prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with heat shock/stress protein-peptide complexes
|
|
US20040136951A1
(en)
|
1997-03-17 |
2004-07-15 |
Human Genome Sciences, Inc. |
Death domain containing receptor 5
|
|
US20050233958A1
(en)
|
1997-03-17 |
2005-10-20 |
Human Genome Sciences, Inc. |
Death domain containing receptor 5
|
|
US20080248046A1
(en)
|
1997-03-17 |
2008-10-09 |
Human Genome Sciences, Inc. |
Death domain containing receptor 5
|
|
US6007821A
(en)
|
1997-10-16 |
1999-12-28 |
Fordham University |
Method and compositions for the treatment of autoimmune disease using heat shock proteins
|
|
US5948646A
(en)
|
1997-12-11 |
1999-09-07 |
Fordham University |
Methods for preparation of vaccines against cancer comprising heat shock protein-peptide complexes
|
|
US8101349B2
(en)
|
1997-12-23 |
2012-01-24 |
Novartis Vaccines And Diagnostics, Inc. |
Gene products differentially expressed in cancerous cells and their methods of use II
|
|
EP1054683B1
(en)
*
|
1998-02-20 |
2007-04-11 |
University Of Miami |
Modified heat shock protein-antigenic peptide complex
|
|
ES2328194T3
(es)
|
1998-05-26 |
2009-11-10 |
Genitrix Llc |
Composiciones y procedimientos de modulacion de una respuesta inmunitaria frente a un antigeno mediante la administracion de celulas recubiertas con citocina.
|
|
US6451316B1
(en)
|
1998-10-05 |
2002-09-17 |
University Of Conneticut Health Center |
Methods for generating antigen-reactive T cells in vitro
|
|
US6797480B1
(en)
|
1998-10-05 |
2004-09-28 |
University Of Connecticut Health Center |
Purification of heat shock/stress protein cell surface receptors and their use as immunotherapeutic agents
|
|
US6475490B1
(en)
|
1998-10-19 |
2002-11-05 |
Fordham University |
Compositions and methods for promoting tissue repair using heat shock proteins
|
|
WO2000052204A2
(en)
|
1999-02-22 |
2000-09-08 |
Orntoft Torben F |
Gene expression in bladder tumors
|
|
US6317435B1
(en)
|
1999-03-08 |
2001-11-13 |
Qualcomm Incorporated |
Method and apparatus for maximizing the use of available capacity in a communication system
|
|
HK1046635B
(en)
|
1999-06-09 |
2009-10-09 |
Immunomedics, Inc. |
Immunotherapy of autoimmune disorders using antibodies which target b-cells
|
|
US6651655B1
(en)
|
2000-01-18 |
2003-11-25 |
Quadrant Technologies Limited |
Inhaled vaccines
|
|
WO2009118248A2
(en)
|
2008-03-26 |
2009-10-01 |
Clariant International Ltd |
Improved optical brightening compositions
|
|
EP1284986A4
(en)
|
2000-04-17 |
2005-08-24 |
James E Rothman |
COMPLEXIZING PROTEIN ANTIGENES AND HEAT SHOCK PROTEINS BY JAVELIN
|
|
US7030219B2
(en)
|
2000-04-28 |
2006-04-18 |
Johns Hopkins University |
B7-DC, Dendritic cell co-stimulatory molecules
|
|
SK18362002A3
(sk)
|
2000-06-26 |
2004-02-03 |
Stressgen Biotechnologies Corporation |
Použitie prostriedku s obsahom fúzneho proteínu
|
|
WO2002012281A2
(en)
|
2000-08-03 |
2002-02-14 |
Johns Hopkins University |
Molecular vaccine linking an endoplasmic reticulum chaperone polypeptide to an antigen
|
|
US7132109B1
(en)
|
2000-10-20 |
2006-11-07 |
University Of Connecticut Health Center |
Using heat shock proteins to increase immune response
|
|
US20070292411A1
(en)
|
2000-11-08 |
2007-12-20 |
Human Genome Sciences, Inc. |
Antibodies That Immunospecifically Bind to TRAIL Receptors
|
|
US20060062786A1
(en)
|
2000-11-08 |
2006-03-23 |
Human Genome Sciences, Inc. |
Antibodies that immunospecifically bind to TRAIL receptors
|
|
WO2004016753A2
(en)
|
2002-08-15 |
2004-02-26 |
Human Genome Sciences, Inc. |
Antibodies that immunospecifically bind to trail receptors
|
|
US20050129616A1
(en)
|
2001-05-25 |
2005-06-16 |
Human Genome Sciences, Inc. |
Antibodies that immunospecifically bind to TRAIL receptors
|
|
US7361341B2
(en)
|
2001-05-25 |
2008-04-22 |
Human Genome Sciences, Inc. |
Methods of treating cancer using antibodies that immunospecifically bind to trail receptors
|
|
US20050214209A1
(en)
|
2001-05-25 |
2005-09-29 |
Human Genome Sciences, Inc. |
Antibodies that immunospecifically bind to TRAIL receptors
|
|
US20050214210A1
(en)
|
2001-05-25 |
2005-09-29 |
Human Genome Sciences, Inc. |
Antibodies that immunospecifically bind to TRAIL receptors
|
|
US7348003B2
(en)
|
2001-05-25 |
2008-03-25 |
Human Genome Sciences, Inc. |
Methods of treating cancer using antibodies that immunospecifically bind to TRAIL receptors
|
|
US7026121B1
(en)
|
2001-06-08 |
2006-04-11 |
Expression Diagnostics, Inc. |
Methods and compositions for diagnosing and monitoring transplant rejection
|
|
US7235358B2
(en)
|
2001-06-08 |
2007-06-26 |
Expression Diagnostics, Inc. |
Methods and compositions for diagnosing and monitoring transplant rejection
|
|
US6905827B2
(en)
|
2001-06-08 |
2005-06-14 |
Expression Diagnostics, Inc. |
Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases
|
|
WO2003005964A2
(en)
|
2001-07-11 |
2003-01-23 |
University Of Miami |
Recombinant vsv for the treatment of tumor cells
|
|
WO2003042661A2
(en)
|
2001-11-13 |
2003-05-22 |
Protein Design Labs, Inc. |
Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer
|
|
US20050019752A1
(en)
|
2001-11-16 |
2005-01-27 |
Genoveffa Franchini |
Novel chimeric rev, tat, and nef antigens
|
|
US7955845B2
(en)
|
2001-11-20 |
2011-06-07 |
Dana Farber Cancer Institute, Inc. |
Modified antigen-presenting cells
|
|
US20050214206A1
(en)
|
2001-12-20 |
2005-09-29 |
Human Genome Sciences, Inc. |
Antibodies that immunospecifically bind to TRAIL receptors
|
|
US20050214207A1
(en)
|
2001-12-20 |
2005-09-29 |
Human Genome Sciences, Inc. |
Antibodies that immunospecifically bind toTRAIL receptors
|
|
US20050214208A1
(en)
|
2001-12-20 |
2005-09-29 |
Human Genome Sciences, Inc. |
Antibodies that immunospecifically bind to TRAIL receptors
|
|
US20050214205A1
(en)
|
2001-12-20 |
2005-09-29 |
Human Genome Sciences, Inc. |
Antibodies that immunospecifically bind to TRAIL receptors
|
|
EP1539197A4
(en)
*
|
2002-02-01 |
2006-08-02 |
Univ Jefferson |
TREATMENT OF TUMOR CELLS FOR USE IN IMMUNOTHERAPY IN CANCER
|
|
KR20040105736A
(ko)
|
2002-02-28 |
2004-12-16 |
안티제닉스 아이엔씨 |
스트레스 단백질의 올리고머화에 기초한 방법 및 산물
|
|
US6984389B2
(en)
|
2002-04-25 |
2006-01-10 |
University Of Connecticut Health Center |
Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality
|
|
RU2376029C2
(ru)
|
2002-04-25 |
2009-12-20 |
Юниверсити Оф Коннектикут Хелт Сентер |
Применение белков теплового шока для улучшения терапевтического эффекта невакцинного лечебного воздействия
|
|
AU2003234469A1
(en)
|
2002-05-02 |
2003-11-17 |
University Of Connecticut Health Center |
Use of heat shock proteins to enhance efficacy of antibody therapeutics
|
|
US20070298041A1
(en)
|
2002-06-28 |
2007-12-27 |
Tomlinson Ian M |
Ligands That Enhance Endogenous Compounds
|
|
US20040091503A1
(en)
|
2002-08-20 |
2004-05-13 |
Genitrix, Llc |
Lectin compositions and methods for modulating an immune response to an antigen
|
|
BR0313650A
(pt)
|
2002-08-20 |
2007-08-14 |
Genitrix Llc |
composição, vetor de expressão, composição de vacina e uso
|
|
US7629440B2
(en)
|
2002-08-20 |
2009-12-08 |
Genitrix, Llc |
Lectin compositions and methods for modulating an immune response to an antigen
|
|
CN104911210A
(zh)
|
2002-10-09 |
2015-09-16 |
衣阿华中央卫生系统 |
使用表达α(1,3)-半乳糖基转移酶的同种异型肿瘤细胞的抗肿瘤免疫
|
|
AU2003301526A1
(en)
|
2002-10-25 |
2004-05-13 |
University Of Connecticut Health Center |
Immunotherapy of cancer through controlled cell lysis
|
|
JP2006514088A
(ja)
|
2003-02-20 |
2006-04-27 |
ユニバーシティー オブ コネティカット ヘルス センター |
癌および感染症の治療における熱ショックタンパク質またはα−２−マクログロブリンを含む組成物の使用方法
|
|
JP4976848B2
(ja)
|
2003-02-20 |
2012-07-18 |
ユニバーシティー オブ コネティカット ヘルス センター |
アルファ（２）マクログロブリン−抗原分子複合体を用いる癌および感染性疾患の治療のための方法および組成物
|
|
WO2004078921A2
(en)
|
2003-02-27 |
2004-09-16 |
University Of Connecticut Health Center |
Methods and compositions for the treatment of cancer and infectious disease using alpha (2) macroglobulin-antigenic molecule complexes
|
|
KR20060026004A
(ko)
|
2003-02-28 |
2006-03-22 |
안티제닉스 아이엔씨 |
당단백질 및 항원성 분자의 올리고머화를 조장하는 렉틴의용도
|
|
US20040197312A1
(en)
|
2003-04-02 |
2004-10-07 |
Marina Moskalenko |
Cytokine-expressing cellular vaccine combinations
|
|
EP1633316A4
(en)
|
2003-05-06 |
2008-04-02 |
Human Genome Sciences Inc |
ANTIBODIES BINDING IMMUNOSIPICALLY TO TRAIL RECEPTORS
|
|
KR100499278B1
(ko)
*
|
2003-07-05 |
2005-07-01 |
학교법인 포항공과대학교 |
로텍산 화합물이 공유결합된 고체 기판 및 이를 이용한바이오칩
|
|
JP2007505147A
(ja)
|
2003-09-12 |
2007-03-08 |
アンティジェニクス インコーポレーテッド |
単純ヘルペスウイルス感染の治療および予防用ワクチン
|
|
AU2004276522B2
(en)
|
2003-09-26 |
2010-12-02 |
Merck Serono Sa |
Leader sequences for use in production of proteins
|
|
WO2005030136A2
(en)
*
|
2003-09-26 |
2005-04-07 |
University Of Miami |
Tumor vaccine
|
|
FR2867982B1
(fr)
*
|
2004-03-26 |
2007-07-20 |
Jean Marie Andrieu |
Procede pour amplifier l'activite de vaccins therapeutiques
|
|
RU2006140377A
(ru)
|
2004-04-16 |
2008-05-27 |
Дженентек, Инк. (Us) |
Способ усиления уничтожения в-клеток
|
|
WO2005120558A2
(en)
|
2004-05-25 |
2005-12-22 |
University Of Connecticut Health Center |
Methods for making compositions comprising heat shock proteins or alpha-2-macroglobulin for the treatment of cancer and infectious disease
|
|
US20080038316A1
(en)
|
2004-10-01 |
2008-02-14 |
Wong Vernon G |
Conveniently implantable sustained release drug compositions
|
|
CA2943949C
(en)
|
2004-10-06 |
2020-03-31 |
Mayo Foundation For Medical Education And Research |
B7-h1 and methods of diagnosis, prognosis, and treatment of cancer
|
|
CA2597511A1
(en)
|
2005-02-24 |
2006-11-23 |
Medical Research Council |
Hivcon: an hiv immunogen and uses thereof
|
|
WO2007030571A2
(en)
|
2005-09-06 |
2007-03-15 |
Molecular Image Inc. |
Identification of targets and development of reagents for testing and molecular imaging of human disease
|
|
CN101057975B
(zh)
|
2006-12-13 |
2012-10-10 |
中国科学院微生物研究所 |
一种抗免疫耐受性和免疫缺陷性病毒的鸡尾酒疫苗及其应用
|
|
US7989173B2
(en)
|
2006-12-27 |
2011-08-02 |
The Johns Hopkins University |
Detection and diagnosis of inflammatory disorders
|
|
US20080206235A1
(en)
|
2006-12-27 |
2008-08-28 |
Johns Hopkins University |
Compositions and methods for stimulating an immune response
|
|
WO2009018500A1
(en)
|
2007-07-31 |
2009-02-05 |
The Johns Hopkins University |
Polypeptide-nucleic acid conjugate for immunoprophylaxis or immunotherapy for neoplastic or infectious disorders
|
|
US20100080773A1
(en)
|
2008-09-26 |
2010-04-01 |
Sdg, Inc. |
Orally Bioavailable Lipid-Based Constructs
|
|
EP2752193B1
(en)
|
2008-03-03 |
2017-01-11 |
The University of Miami |
Allogeneic cancer cell-based immunotherapy
|
|
WO2009117116A2
(en)
|
2008-03-20 |
2009-09-24 |
University Of Miami |
Heat shock protein gp96 vaccination and methods of using same
|
|
IL190438A0
(en)
|
2008-03-25 |
2008-12-29 |
K M B Y Ltd |
A method of setting a drill for drilling a hole in a bone coaxial to the hole in the nail and aiming device for realizing this method
|
|
CA2720173A1
(en)
|
2008-04-02 |
2009-10-08 |
Sanofi-Aventis |
Highly bridged peptides from actinomadura namibiensis
|
|
WO2010009735A2
(en)
|
2008-07-23 |
2010-01-28 |
Dako Denmark A/S |
Combinatorial analysis and repair
|
|
WO2010037408A1
(en)
|
2008-09-30 |
2010-04-08 |
Curevac Gmbh |
Composition comprising a complexed (m)rna and a naked mrna for providing or enhancing an immunostimulatory response in a mammal and uses thereof
|
|
US20110223196A1
(en)
|
2008-11-21 |
2011-09-15 |
University Of Miami |
Hiv/siv vaccines for the generation of mucosal and systemic immunity
|
|
HRP20170908T1
(hr)
|
2008-12-09 |
2017-09-22 |
F. Hoffmann - La Roche Ag |
Protutijela anti-pd-l1 i njihova uporaba za poboljšanje funkcije t-stanice
|
|
EP2387415A1
(en)
|
2009-01-16 |
2011-11-23 |
AGIRx Limited |
Vaccine compositions
|
|
WO2010088927A1
(en)
|
2009-02-09 |
2010-08-12 |
Curevac Gmbh |
Use of pei for the improvement of endosomal release and expression of transfected nucleic acids, complexed with cationic or polycationic compounds
|
|
RU2015117604A
(ru)
|
2009-04-03 |
2015-10-27 |
Эйдженус Инк. |
Способы получения и применения мультишаперон-антигенных комплексов
|
|
US20110053829A1
(en)
|
2009-09-03 |
2011-03-03 |
Curevac Gmbh |
Disulfide-linked polyethyleneglycol/peptide conjugates for the transfection of nucleic acids
|
|
US9459246B2
(en)
|
2009-09-08 |
2016-10-04 |
Nodality, Inc. |
Induced intercellular communication
|
|
WO2011069529A1
(en)
|
2009-12-09 |
2011-06-16 |
Curevac Gmbh |
Mannose-containing solution for lyophilization, transfection and/or injection of nucleic acids
|
|
WO2011069528A1
(en)
|
2009-12-09 |
2011-06-16 |
Curevac Gmbh |
Lyophilization of nucleic acids in lactate-containing solutions
|
|
IL323000A
(en)
|
2010-03-05 |
2025-10-01 |
Univ Johns Hopkins |
Compositions and methods for antibodies and fusion proteins targeted for immune modulation
|
|
WO2011131472A1
(en)
|
2010-04-22 |
2011-10-27 |
Institut Gustave Roussy |
Compounds and uses thereof to induce an immunogenic cancer cell death in a subject
|
|
US8865653B2
(en)
|
2010-04-22 |
2014-10-21 |
Institut Gustave Roussy |
Method of treatment for immunogenic treatment resistant cancer
|
|
EP2571522A4
(en)
|
2010-05-21 |
2013-11-20 |
Univ Miami |
CANCER TREATMENT
|
|
KR20140045341A
(ko)
|
2011-02-23 |
2014-04-16 |
유니버시티 오브 마이애미 |
Siv/hiv로부터의 보호를 위한 조합된 세포 기반의 gp96-ig-siv/hiv, 재조합 gp120 단백질 백신접종
|
|
CA2874998A1
(en)
|
2011-05-27 |
2012-12-06 |
Cytocure Llc |
Methods, compositions, and kits for the treatment of cancer
|
|
JP6518199B6
(ja)
|
2013-03-15 |
2019-06-12 |
ノヴェロジックス・バイオテクノロジー，インコーポレーテッド |
Ｍｉｃａおよびｍｉｃｂタンパク質に対する抗体
|
|
US20160030659A1
(en)
|
2013-03-15 |
2016-02-04 |
Novelogics Biotechnology, Inc. |
Methods and devices for removal of immunosuppressive ligands
|